» Articles » PMID: 2453883

Mapping Antigenic Domains Expressed by Chlamydia Trachomatis Major Outer Membrane Protein Genes

Overview
Specialty Science
Date 1988 Jun 1
PMID 2453883
Citations 157
Authors
Affiliations
Soon will be listed here.
Abstract

Chlamydia trachomatis is an obligate prokaryotic intracellular pathogen of humans that infects mucosal epithelial cells. Exposed domains of its major outer membrane protein (MOMP) are both serotyping and protective antigenic determinants. To identify these domains, we have cloned and epitope-mapped the genes of serovars A, C (C serogroup) and L2, B (B serogroup) with a panel of monoclonal antibodies (mAbs). Predominantly conserved regions of the genes of both serogroups are interspersed with four short variable domains (I-IV). Recombinant phage clones expressing specific MOMP antigenic determinants revealed that protective serotype-specific recognized epitopes in variable domains I and II. Protective subspecies and serogroup-specific mAbs recognized overlapping determinants in variable domain IV near the C terminus. A nonprotective species-specific mAb mapped to an invariant peptide of nine residues contained within variable domain IV. In the intact chlamydial organism of serovar B, variable domains II and IV were susceptible to proteolytic digestion, whereas both N and C termini were protected. These results suggest an arrangement of MOMP in the outer membrane in which three of the four variable domains are exposed to the outside and in which both N and C termini are presumably oriented toward the periplasmic space. This molecular analysis of MOMP antigenic determinants and their surface topology on intact chlamydiae will be useful toward the development of a recombinant subunit or synthetic chlamydial vaccine.

Citing Articles

Structural Assessment of Major Outer Membrane Protein (MOMP)-Derived Vaccine Antigens and Immunological Profiling in Mice with Different Genetic Backgrounds.

Roe S, Zhu T, Slepenkin A, Berges A, Fairman J, de la Maza L Vaccines (Basel). 2024; 12(7).

PMID: 39066427 PMC: 11281497. DOI: 10.3390/vaccines12070789.


Advances in Vaccination: Unveiling the Potential of Major Outer Membrane Protein Derivative Constructs.

Kiekens C, Morre S, Vanrompay D Microorganisms. 2024; 12(6).

PMID: 38930578 PMC: 11205628. DOI: 10.3390/microorganisms12061196.


Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG.

Slepenkin A, Pal S, Rasley A, Coleman M, de la Maza L NPJ Vaccines. 2024; 9(1):104.

PMID: 38858418 PMC: 11164897. DOI: 10.1038/s41541-024-00880-6.


Metabolic dormancy in treated with different antibiotics.

Rockey D, Wang X, Debrine A, Grieshaber N, Grieshaber S Infect Immun. 2024; 92(2):e0033923.

PMID: 38214508 PMC: 10863404. DOI: 10.1128/iai.00339-23.


Determination of the safety and efficacy of recombinant Chlamydia muridarum MOMP vaccines, formulated with CpG-1826 and 70%, 50%, 30% or 10% concentrations of Montanide ISA-720 VG, to elicit protective immune responses against a C. muridarum....

de la Maza L, Slepenkin A, Pal S, Rasley A, Coleman M Res Sq. 2024; .

PMID: 38168233 PMC: 10760204. DOI: 10.21203/rs.3.rs-3688658/v1.


References
1.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

2.
Berzofsky J, Cease K, Cornette J, Spouge J, Margalit H, Berkower I . Protein antigenic structures recognized by T cells: potential applications to vaccine design. Immunol Rev. 1987; 98:9-52. DOI: 10.1111/j.1600-065x.1987.tb00518.x. View

3.
GRAYSTON J, Wang S . New knowledge of chlamydiae and the diseases they cause. J Infect Dis. 1975; 132(1):87-105. DOI: 10.1093/infdis/132.1.87. View

4.
Caldwell H, Schachter J . Antigenic analysis of the major outer membrane protein of Chlamydia spp. Infect Immun. 1982; 35(3):1024-31. PMC: 351150. DOI: 10.1128/iai.35.3.1024-1031.1982. View

5.
Caldwell H, Perry L . Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein. Infect Immun. 1982; 38(2):745-54. PMC: 347801. DOI: 10.1128/iai.38.2.745-754.1982. View